celebrating our 20th anniversary in 2018, ventas is an s&p; 500 company and leading real estate investment trust (reit). as the leading capital provider for healthcare real estate with more than $40 billion of investments under our belt, we own communities where patients and their families receive health and healing; where world class researchers discover treatments for disease; and where seniors live with dignity. our diverse property portfolio combines seniors housing, life science research and innovation centers, medical office buildings, health system complexes, and post-acute care facilities. thanks to our financial strength and liquidity, our stock and robust dividend provides secure retirement savings and income to pensioners, firefighters, teachers and individuals around the world. ventas takes our esg (environment, social & governance) commitments seriously, emphasizing strong corporate governance; encouraging community engagement through social and financial support to the co

Company profile
Ticker
VTR
Exchange
Website
CEO
Debra Cafaro
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
VENCOR INC, VENTAS INC
SEC CIK
Corporate docs
Subsidiaries
1425 Hunt Club, LLC • 1445 Hunt Club, LLC • 14851 Yorba Street, LLC • 200 Andrews, LLC • 2010 Union Limited Partnership • 311 South Sarah, LLC • 3737 Market Investment Fund, LLC • 4210 Duncan, LLC • 4220 Duncan Holding, LLC • 4220 Duncan, LLC ...
IRS number
611055020
VTR stock data
Latest filings (excl ownership)
10-Q
2023 Q3
Quarterly report
3 Nov 23
8-K
Results of Operations and Financial Condition
2 Nov 23
8-K
Entry into a Material Definitive Agreement
12 Sep 23
10-Q
2023 Q2
Quarterly report
4 Aug 23
8-K
Results of Operations and Financial Condition
3 Aug 23
8-K
Entry into a Material Definitive Agreement
13 Jun 23
8-K
Ventas Realty, Limited Partnership Announces Proposed Private Placement of $500 Million of Exchangeable Senior Notes
8 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
19 May 23
10-Q
2023 Q1
Quarterly report
9 May 23
8-K
Results of Operations and Financial Condition
8 May 23
Transcripts
VTR
Earnings call transcript
2023 Q3
3 Nov 23
VTR
Earnings call transcript
2023 Q2
4 Aug 23
VTR
Earnings call transcript
2023 Q1
9 May 23
VTR
Earnings call transcript
2022 Q4
10 Feb 23
VTR
Earnings call transcript
2022 Q3
4 Nov 22
VTR
Earnings call transcript
2022 Q2
5 Aug 22
VTR
Earnings call transcript
2022 Q1
6 May 22
VTR
Earnings call transcript
2021 Q4
18 Feb 22
VTR
Earnings call transcript
2021 Q3
5 Nov 21
VTR
Earnings call transcript
2021 Q2
8 Aug 21
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 491.75 mm | 491.75 mm | 491.75 mm | 491.75 mm | 491.75 mm | 491.75 mm |
Cash burn (monthly) | (no burn) | (no burn) | 25.60 mm | 7.14 mm | (no burn) | (no burn) |
Cash used (since last report) | n/a | n/a | 59.03 mm | 16.47 mm | n/a | n/a |
Cash remaining | n/a | n/a | 432.71 mm | 475.28 mm | n/a | n/a |
Runway (months of cash) | n/a | n/a | 16.9 | 66.5 | n/a | n/a |
Institutional ownership, Q3 2023
93.1% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 593 |
Opened positions | 62 |
Closed positions | 77 |
Increased positions | 208 |
Reduced positions | 223 |
13F shares | Current |
---|---|
Total value | 15.79 tn |
Total shares | 374.75 mm |
Total puts | 655.70 k |
Total calls | 753.50 k |
Total put/call ratio | 0.9 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 64.48 mm | $2.72 tn |
BLK Blackrock | 42.19 mm | $1.78 tn |
STT State Street | 28.04 mm | $1.19 tn |
JPM JPMorgan Chase & Co. | 23.76 mm | $1.00 tn |
FMR | 22.25 mm | $937.24 bn |
PFG Principal Financial Group Inc - Registered Shares | 19.69 mm | $829.62 bn |
APG Asset Management US | 17.08 mm | $719.48 bn |
Geode Capital Management | 9.44 mm | $397.10 bn |
Centersquare Investment Management | 6.64 mm | $279.77 bn |
Dimensional Fund Advisors | 5.84 mm | $246.23 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
6 Dec 23 | Sumit Roy | Common Stock | Grant | Acquire A | No | No | 46.06 | 32.566 | 1.50 k | 9,574.209 |
6 Dec 23 | Maurice S Smith | Common Stock | Grant | Acquire A | No | No | 46.06 | 32.566 | 1.50 k | 14,772.442 |
6 Dec 23 | Shelton James D | Common Stock | Grant | Acquire A | No | No | 46.06 | 16.283 | 749.99 | 71,270.807 |
6 Dec 23 | Martino Roxanne M | Common Stock | Grant | Acquire A | No | No | 46.06 | 32.566 | 1.50 k | 47,961.272 |
20 Nov 23 | Sumit Roy | Common Stock | Grant | Acquire A | No | No | 44.96 | 33.363 | 1.50 k | 9,541.643 |
News
Wells Fargo Maintains Overweight on Ventas, Lowers Price Target to $47
13 Nov 23
Jim Cramer Asks Why The World's Largest Healthcare Products Company Has 'An Ill-Advised Strategy'
8 Nov 23
Ventas, Welltower Have New Growth in Senior Housing Portfolios: Analyst Says What's Next
7 Nov 23
Expert Ratings for Ventas
7 Nov 23
Appian To Rally Around 47%? Here Are 10 Top Analyst Forecasts For Tuesday
7 Nov 23
Press releases
Ventas Declares Fourth Quarter 2023 Dividend of $0.45 per Common Share
5 Dec 23
Ventas to Participate in Investor Meetings at Nareit's REITworld 2023 Annual Conference
10 Nov 23
Ventas Reports 2023 Third Quarter Results
2 Nov 23
Ventas Releases 2022-2023 Corporate Sustainability Report
25 Oct 23
Ventas Announces Third Quarter 2023 Earnings Date and Conference Call
18 Oct 23